© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
IDH1 inhibitor delayed progression of this often aggressive cancer of the bile ducts.
The team reasoned that if reducing DNA repair killed some cells, then a dramatically reducing DNA repair could kill even more.
Recent legislation may help narrow the gap between FDA approval of cancer medications for adults and children.
People who paid more money out-of-pocket filled fewer prescriptions and had shorter overall survival.
This mix-up may help explain why cancer drugs aren’t always as effective as hoped.
First KRAS targeted therapy shows promise for lung and colon cancer
Prestigious prize goes to researchers who identified B cells and T cells and others who invented the HER2 targeted cancer therapy Herceptin.
Ken has lived with and in the shadow of melanoma since 1995, but he isn’t your typical patient and he hasn’t been cured of melanoma.
Selpercatinib shrank tumors in 68% of patients previously treated with chemotherapy.
Half of study participants treated with AMG 510 saw their tumors shrink, and only one experienced disease progression.
Betting on basic science is leading to breakthroughs in immune checkpoint inhibitors, CAR-T, targeted therapies, cancer vaccines and more.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
